Targeting Phenotypic Plasticity in Prostate Cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Molecular Biology Reports

• Publication date

  2017-07-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s40610-017-0070-x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis.

  2017cited by this paper
• A short-term intervention with selenium affects expression of genes implicated in the epithelial-to-mesenchymal transition in the prostate

  2017cited by this paper
• Litchi seed extracts diminish prostate cancer progression via induction of apoptosis and attenuation of EMT through Akt/GSK-3β signaling

  2017cited by this paper
• Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond.

  2017cited by this paper
• Curcumin mediates reversion of HGF-induced epithelial-mesenchymal transition via inhibition of c-Met expression in DU145 cells.

  2016cited by this paper
• Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane Fluidity.

  2016cited by this paper
• A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516

  2016cited by this paper
• A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor

  2016cited by this paper
• Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell

  2016cited by this paper
• Chemical regulators of epithelial plasticity reveal a nuclear receptor pathway controlling myofibroblast differentiation

  2016cited by this paper
• Role of EMT in Metastasis and Therapy Resistance

  2016cited by this paper
• Galeterone and VNPT55 disrupt Mnk‐eIF4E to inhibit prostate cancer cell migration and invasion

  2016cited by this paper
• Saikosaponin-d: A potential chemotherapeutics in castration resistant prostate cancer by suppressing cancer metastases and cancer stem cell phenotypes.

  2016cited by this paper
• Rhapontigenin inhibits TGF-β-mediated epithelial‑mesenchymal transition via the PI3K/AKT/mTOR pathway and is not associated with HIF-1α degradation.

  2016cited by this paper
• EMT, cell plasticity and metastasis

  2016cited by this paper
• Salinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathway.

  2016cited by this paper
• Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine

  2016cited by this paper
• CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling

  2016cited by this paper
• Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases

  2016cited by this paper
• Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells.

  2016cited by this paper
• Simvastatin blocks TGF-β1-induced epithelial-mesenchymal transition in human prostate cancer cells.

  2016cited by this paper
• Saracatinib as a metastasis inhibitor in metastatic castration‐resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study

  2016cited by this paper
• Epithelial–mesenchymal transition: a new target in anticancer drug discovery

  2016cited by this paper
• Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability

  2016cited by this paper
• Targeting metastasis

  2016cited by this paper
• High-throughput screening identifies artesunate as selective inhibitor of cancer stemness: Involvement of mitochondrial metabolism.

  2016cited by this paper
• Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-β1 by attenuating the upregulation of SphK1.

  2016cited by this paper
• Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells.

  2015cited by this paper
• Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCϵ, Stat3, and Epithelial-to-Mesenchymal Transition Markers

  2015cited by this paper
• Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer

  2015cited by this paper
• Berberine Inhibits the Metastatic Ability of Prostate Cancer Cells by Suppressing Epithelial-to-Mesenchymal Transition (EMT)-Associated Genes with Predictive and Prognostic Relevance

  2015cited by this paper
• Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.

  2015cited by this paper
• Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.

  2015cited by this paper
• EMT is not required for lung metastasis but contributes to chemoresistance

  2015cited by this paper
• Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells.

  2015cited by this paper
• Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity.

  2015cited by this paper
• EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer

  2015cited by this paper
• Valproic acid (VPA) inhibits the epithelial–mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4

  2015cited by this paper
• Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells

  2015cited by this paper
• Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.

  2014cited by this paper
• Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway.

  2014cited by this paper
• Antitumor Effects of Saffron-Derived Carotenoids in Prostate Cancer Cell Models

  2014cited by this paper
• Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell

  2014cited by this paper
• α-Solanine Inhibits Invasion of Human Prostate Cancer Cell by Suppressing Epithelial-Mesenchymal Transition and MMPs Expression

  2014cited by this paper
• Muscadine grape skin extract reverts snail-mediated epithelial mesenchymal transition via superoxide species in human prostate cancer cells

  2014cited by this paper
• Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer

  2014cited by this paper
• Mesenchymal-mode migration assay and antimetastatic drug screening with high-throughput microfluidic channel networks.

  2014cited by this paper
• Targeting EMT in cancer: opportunities for pharmacological intervention.

  2014cited by this paper
• Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.

  2014cited by this paper
• Tumor plasticity interferes with anti-tumor immunity.

  2014cited by this paper
• Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies.

  2014cited by this paper
• Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer.

  2014cited by this paper
• Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment

  2014cited by this paper
• Screening therapeutic EMT blocking agents in a three-dimensional microenvironment.

  2013cited by this paper
• The phytoalexin camalexin mediates cytotoxicity towards aggressive prostate cancer cells via reactive oxygen species

  2013cited by this paper
• Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

  2013cited by this paper
• Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness.

  2013cited by this paper
• Salinomycin: a novel anti-cancer agent with known anti-coccidial activities.

  2013cited by this paper
• Phenotypic High-Throughput Screening Elucidates Target Pathway in Breast Cancer Stem Cell–Like Cells

  2012cited by this paper
• A 1536-Well Quantitative High-Throughput Screen to Identify Compounds Targeting Cancer Stem Cells

  2012cited by this paper
• Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells.

  2012cited by this paper
• Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.

  2012cited by this paper
• Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

  2012cited by this paper
• Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

  2012cited by this paper
• Identification of a selective small molecule inhibitor of breast cancer stem cells.

  2012cited by this paper
• EMT and dissemination precede pancreatic tumor formation.

  2012cited by this paper
• A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma

  2012cited by this paper
• Identification and optimization of small molecules that restore E-cadherin expression and reduce invasion in colorectal carcinoma cells.

  2011cited by this paper
• Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?

  2011cited by this paper
• Diosgenin suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition by down-regulation of Mdm2 and vimentin.

  2011cited by this paper
• 3D Models of Epithelial-Mesenchymal Transition in Breast Cancer Metastasis

  2011cited by this paper
• Mechanisms of nitric oxide-mediated inhibition of EMT in cancer

  2010cited by this paper
• Effect of the Specific Src Family Kinase Inhibitor Saracatinib on Osteolytic Lesions Using the PC-3 Bone Model

  2010cited by this paper
• Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.

  2010cited by this paper
• Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells

  2010cited by this paper
• Role of androgens and the androgen receptor in epithelial‐mesenchymal transition and invasion of prostate cancer cells

  2010cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009influential reference
• Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction

  2009cited by this paper
• Identification of selective inhibitors of cancer stem cells by high-throughput screening.

  2009cited by this paper
• Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells.

  2008cited by this paper
• A novel anti-cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells

  2008cited by this paper
• The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.

  2008cited by this paper
• Efficient tumour formation by single human melanoma cells

  2008cited by this paper
• Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?

  2005cited by this paper
• The fallacy of epithelial mesenchymal transition in neoplasia.

  2005cited by this paper
• P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo.

  1996cited by this paper
• Role of cell-matrix contacts in cell migration and epithelial-mesenchymal transformation.

  1990cited by this paper

• High content screening identifies monensin as an EMT-selective cytotoxic compound

  2019cites this paper
• Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity

  2019cites this paper
• Microfluidic-Based Mechanical Phenotyping of Androgen-Sensitive and Non-sensitive Prostate Cancer Cells Lines

  2019cites this paper